|
The Prescription Pricing Authority's Medical Directorate was established in 1992 and provides advice on a wide range of prescribing issues connected with existing services and with the development of new and improved services.
The PPA's PACT information system, provides GPs with frequent reports about their prescribing patterns. The centre pages of the reports focus on a particular medicine related issues. The Medical Director gives presentations on prescribing matters and the PPA information services and organises conferences on prescribing issues for professional organisations . The PPA maintain close links with Health Authority medical and pharmaceutical advisors and the Authority liase with them through local, regional and national meetings. In addition, the Medical Director maintains a dialogue with the Royal College of General Practitioners, the British Medical Association, the Drug Safety Research Unit, the Royal Pharmaceutical Society, academia, the pharmaceutical industry and a wide range of other bodies. The Directorate of Pharmaceutical Advisory Services works closely with the Medical Directorate on prescribing issues. Led by two pharmacists, the Directorate has two main areas of activity, pharmaceutical issues and Central Quality Assurance. The Directorate has ISO 9001 accreditation for Central Quality Assurance services. There are seven areas of pharmaceutical activity:
Central Quality Assurance carries out the reprocessing of a statistical sample of the prescription forms processed by the Prescription Pricing Service. It aims to monitor standards and measure the accuracy of prescription data captured and payments to contractors. |